Brown, Lisle/Cummings, Inc. Inovio Pharmaceuticals, Inc. Transaction History
Brown, Lisle/Cummings, Inc.
- $307 Billion
- Q2 2024
Shares
2 transactions
Others Institutions Holding INO
# of Institutions
11Shares Held
281KCall Options Held
0Put Options Held
0-
Pathstone Family Office, LLC Englewood, NJ148KShares$823,5750.0% of portfolio
-
ETF Managers Group, LLC Summit, NJ86.4KShares$479,3310.0% of portfolio
-
Brainard Capital Management LLC Austin, TX16.7KShares$92,4960.01% of portfolio
-
Tiaa, Fsb St. Louis, MO14.4KShares$79,8250.0% of portfolio
-
Personal Capital Advisors Corp11.3KShares$62,7150.0% of portfolio
About INOVIO PHARMACEUTICALS, INC.
- Ticker INO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 249,400,000
- Market Cap $1.38B
- Description
- Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA se...